Fulgent Genetics, Inc. (FLGT)
19.61
-0.34
(-1.70%)
USD |
NASDAQ |
Aug 28, 16:00
19.63
+0.02
(+0.10%)
After-Hours: 20:00
Fulgent Genetics Gross Profit Margin (Quarterly) : 27.02% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 27.02% |
| March 31, 2026 | 27.35% |
| December 31, 2025 | 36.67% |
| September 30, 2025 | 39.83% |
| June 30, 2025 | 39.66% |
| March 31, 2025 | 35.88% |
| December 31, 2024 | 39.18% |
| September 30, 2024 | 34.54% |
| June 30, 2024 | 34.49% |
| March 31, 2024 | 31.19% |
| December 31, 2023 | 33.01% |
| September 30, 2023 | 44.74% |
| June 30, 2023 | 27.43% |
| March 31, 2023 | 25.45% |
| December 31, 2022 | 16.21% |
| September 30, 2022 | 41.73% |
| June 30, 2022 | 50.82% |
| March 31, 2022 | 75.45% |
| December 31, 2021 | 74.95% |
| September 30, 2021 | 80.58% |
| June 30, 2021 | 76.66% |
| March 31, 2021 | 79.39% |
| December 31, 2020 | 82.45% |
| Date | Value |
|---|---|
| September 30, 2020 | 74.18% |
| June 30, 2020 | 55.30% |
| March 31, 2020 | 47.67% |
| December 31, 2019 | 56.67% |
| September 30, 2019 | 62.45% |
| June 30, 2019 | 57.03% |
| March 31, 2019 | 44.73% |
| December 31, 2018 | 51.19% |
| September 30, 2018 | 53.56% |
| June 30, 2018 | 52.89% |
| March 31, 2018 | 40.43% |
| December 31, 2017 | 40.55% |
| September 30, 2017 | 49.63% |
| June 30, 2017 | 59.50% |
| March 31, 2017 | 64.96% |
| December 31, 2016 | 68.18% |
| September 30, 2016 | 57.23% |
| June 30, 2016 | 64.47% |
| March 31, 2016 | 62.09% |
| December 31, 2015 | 6.03% |
| September 30, 2015 | 0.00% |
| June 30, 2015 | 0.00% |
| March 31, 2015 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Quest Diagnostics, Inc. | 32.53% |
| Labcorp Holdings, Inc. | 27.71% |
| OPKO Health, Inc. | 37.32% |
| Psychemedics Corp. | -- |
| NeoGenomics, Inc. | 44.06% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -7.94% |
| Return on Assets | -7.28% |
| Return on Invested Capital | -7.88% |
| Profit Margin (Quarterly) | -34.80% |
| Operating Margin (Quarterly) | -39.39% |
| Return on Net Operating Assets | -17.93% |